| __timestamp | Dr. Reddy's Laboratories Limited | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 72471000 |
| Thursday, January 1, 2015 | 42585000000 | 89204000 |
| Friday, January 1, 2016 | 45702000000 | 106010000 |
| Sunday, January 1, 2017 | 46372000000 | 137905000 |
| Monday, January 1, 2018 | 46910000000 | 159888000 |
| Tuesday, January 1, 2019 | 48890000000 | 158425000 |
| Wednesday, January 1, 2020 | 50129000000 | 200677000 |
| Friday, January 1, 2021 | 54559000000 | 304759000 |
| Saturday, January 1, 2022 | 62081000000 | 377221000 |
| Sunday, January 1, 2023 | 105931000000 | 336361000 |
| Monday, January 1, 2024 | 77201000000 |
Infusing magic into the data realm
In the competitive pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Dr. Reddy's Laboratories Limited and Supernus Pharmaceuticals, Inc. offer a fascinating comparison in this regard. Over the past decade, Dr. Reddy's has consistently maintained higher SG&A expenses, peaking at approximately 106 billion in 2023, a staggering 1,400% increase compared to Supernus's peak of around 377 million in 2022. This disparity highlights Dr. Reddy's expansive operational scale and market reach. However, Supernus's leaner SG&A structure, with expenses growing by about 420% from 2014 to 2022, suggests a more focused approach. The data from 2024 is incomplete, but the trend indicates Dr. Reddy's might be optimizing costs, as seen in the reduced expenses compared to 2023. This analysis underscores the strategic choices each company makes in balancing growth and efficiency.
Eli Lilly and Company vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Novartis AG vs Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Who Optimizes SG&A Costs Better? Biogen Inc. or Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Merus N.V.
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.
Comparing SG&A Expenses: Supernus Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc. Trends and Insights